Skip to main content
Jonathan Fletcher, MD, Medical Genetics, Boston, MA

JonathanAlfredFletcherMD

Medical Genetics • Boston, MA

Clinical Cytogenetics

Associate Professor of Pathology, Brigham and Women's Hospital

Join to view full profile

Dr. Fletcher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fletcher's full profile

Already have an account?

  • Office

    75 Francis St
    # Brigham
    Boston, MA 02115
    Phone+1 617-732-7883

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1988
  • Boston University Medical Center
    Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1981 - 1985
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1981

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1985 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Clinical Cytogenetics
    American Board of Medical Genetics and Genomics Clinical Cytogenetics

Publications & Presentations

PubMed

Journal Articles

  • LMTK3 Is Essential for Oncogenic KIT Expression in KIT-Mutant GIST and Melanoma  
    Jonathan A Fletcher, William H Fleming, Nature

Press Mentions

  • Demetri’s Team Approach Translates into Success in Sarcoma Research
    Demetri’s Team Approach Translates into Success in Sarcoma ResearchFebruary 10th, 2016

Grant Support

  • Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatmentUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
  • Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatmentUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
  • Core--Molecular CytogeneticsNational Cancer Institute2000–2002
  • Translocation Of 8-13 In Stem-Cell Leukemia/LymphomaNational Cancer Institute1997–1999
  • Tumor Suppressor Loci In MesotheliomaNational Cancer Institute1996–1998
  • Molecular Cytogenetics Of Solid TumorsNational Cancer Institute1990–1994

Dr. Jonathan Fletcher, Dr. Jonathan Fletcher, MD, Dr. J Fletcher, Dr. Jonathan Alfred Fletcher